Adrenocortical carcinoma and ovarian cancer
Clinical research at Universitaetsklinikum Wuerzburg AöR includes solid tumour studies in adrenocortical carcinoma and ovarian cancer, with attention to postoperative disease control and treatment strategies for high-risk malignancies.
- adjuvant treatment
- recurrence-free survival
- high-risk cancer
The sponsor’s oncology portfolio also reflects interest in treatment approaches for patients requiring additional systemic therapy after surgery.
Multiple myeloma and newly diagnosed multiple myeloma
Several studies focus on multiple myeloma, including newly diagnosed and relapsed or treatment-resistant disease, with research spanning induction treatment, transplant-related care, maintenance therapy, and response depth.
- minimal residual disease
- progression-free survival
- autologous stem cell transplant
These trials also examine combinations of established anti-myeloma agents within modern treatment sequences.
CAR-T cell therapy and cytokine release syndrome
The sponsor is active in cellular immunotherapy, particularly CAR-T cell therapy for hematologic malignancies and the management of cytokine release syndrome associated with this treatment.
- genetically modified T-cells
- immune-related toxicity
- supportive care in immunotherapy
Research in this area includes both antitumour activity and strategies to reduce treatment-related complications during cellular therapy.
Chronic lymphocytic leukemia and mantle cell lymphoma
Hematologic oncology interests extend to chronic lymphocytic leukemia and mantle cell lymphoma, indicating involvement in lymphoid malignancies and immune-based treatment contexts.
- lymphoid neoplasms
- relapsed disease
- targeted therapy
These areas align with broader work in advanced blood cancers and treatment-resistant disease.
Breast cancer and plasma cell disorders
The trial portfolio also includes breast cancer alongside plasma cell disorders such as multiple myeloma, showing interest in both solid tumours and haematological malignancies.
- oncology
- systemic anti-cancer therapy
- specialist cancer care
Research activity is supported through collaboration across multiple sites in Europe, with ongoing recruitment across the sponsor’s active studies.
